Health Topics — Endocrine, Reproductive & Limbic
When Stress Is Affecting Your Testosterone
For the man whose energy, drive, mood, and vitality shifted during a period of sustained stress — and who suspects the two things are connected. The research confirms they are.
The hard stretch at work that went on for eighteen months. The financial pressure that never quite lifted. The period of caring for someone else while running on empty yourself. At some point during it — or maybe after it, when things should have been better — something changed. The energy that used to be baseline isn't there. The motivation is flatter. Recovery from exercise takes longer. Sleep isn't as restorative. The drive that felt automatic now requires effort.
If you have noticed the timing of those changes, you are tracking something real. Chronic stress suppresses testosterone — directly, through documented biology, at three separate points in the hormonal chain. The symptoms you are experiencing may be stress chemistry, not ageing.
How chronic stress suppresses testosterone
Testosterone production in men is governed by the HPG axis — a cascade that begins in the hypothalamus, passes through the pituitary gland, and ends in the Leydig cells of the testes. The hypothalamus releases GnRH, which signals the pituitary to release LH, which signals the Leydig cells to produce testosterone. Disruption at any point in the chain reduces the testosterone output at the end of it.
Chronic stress disrupts the chain at all three points simultaneously. Sustained cortisol slows the GnRH pulse that starts the cascade. It reduces the pituitary's sensitivity to GnRH, so less LH is released even when the signal arrives. And glucocorticoid receptors in the Leydig cells themselves reduce their response to LH when cortisol is chronically elevated — so even a reduced LH signal produces less testosterone than it should. Three separate mechanisms, all pointing in the same direction.
The research on this is not subtle. Combat deployment studies, medical residency studies, and occupational stress research consistently show testosterone reductions of 10–20% under sustained stress conditions in men with no other hormonal pathology. That is a clinically significant reduction — large enough to produce the symptoms that motivated you to search for an explanation. And it is not a consequence of ageing or genetics. It is a response to load.
Why the number on a blood test may not tell the full story
Many men who go through a period of chronic stress, notice the symptoms, and get a testosterone panel find their levels in the low-normal range — technically within reference range, but not where they were. Reference ranges are wide. A man who was functioning at the upper third of normal and has dropped to the lower third under stress load may be within range and still experiencing the symptomatic consequences of a significant personal reduction.
The more diagnostically useful question is not whether the number is in range, but whether it has changed — and whether the change tracks with the stress period. Most men don't have pre-stress baseline testosterone data. But the pattern — symptoms emerging during or after a prolonged high-stress period, gradual rather than sudden onset, affecting energy and mood and motivation more than specific physical markers — is consistent with HPA-driven HPG suppression rather than primary hypogonadism.
This distinction matters because the intervention is different. Primary hypogonadism — a problem with the testes themselves — has specific treatments. HPA-driven testosterone suppression is, in principle, addressable at the upstream source: the chronic stress load that is suppressing the cascade. Addressing the hormone number without addressing the cortisol driving it is treating downstream of the problem.
Where the endocannabinoid system and CBG connect
The endocannabinoid system modulates the HPA axis at every level where chronic stress suppresses the HPG cascade. CB1 receptors in the hypothalamus participate in the feedback mechanism that terminates cortisol responses. Endocannabinoid signalling in the limbic system — which initiates the stress cascade through the amygdala-hypothalamus pathway — modulates how stress signals are amplified and prolonged. When ECS tone is depleted by chronic stress, the cortisol response becomes less efficiently regulated, and the suppression of testosterone production downstream becomes more sustained.
CBG's most relevant research for this picture is the Cuttler (2024) human trial — the first randomised controlled trial of CBG for stress and anxiety, which found significant reductions in stress and anxiety compared to placebo. Whether CBG reduces cortisol specifically, and whether that reduction translates to downstream improvements in testosterone, has not been tested in a controlled trial. The pathway is coherent. The clinical evidence connecting the two has not been generated.
What can be said honestly: CBG preparations act on the stress biology that sits upstream of the testosterone suppression. Addressing the cortisol load is the mechanistically coherent approach for stress-driven testosterone decline. The research on CBG addresses the stress end of that pathway. The testosterone end has not been studied in a human trial with CBG or CBD specifically.
On testosterone symptoms and clinical care
Symptoms consistent with low testosterone — persistent fatigue, reduced libido, mood changes, reduced motivation, impaired recovery — warrant clinical assessment. A doctor can order a testosterone panel, assess total and free testosterone, and help determine whether the pattern is consistent with stress-driven suppression or another cause. Significant or prolonged symptoms should not be self-managed without evaluation.
If you are considering a CBD or CBG preparation alongside other approaches, the drug interaction consideration applies: some medications prescribed for testosterone-related conditions are CYP450 substrates. Discuss with your prescribing clinician.
The connection between chronic stress and reduced testosterone is not speculative. It is documented biology — three mechanisms, consistent human research, measurable effects. The framing this archive offers is not "CBG raises testosterone." It is: if chronic stress is suppressing your testosterone through the HPA-HPG pathway, then addressing the stress load is the most mechanistically coherent upstream intervention. The stress research is where the human evidence sits. That is what we can say honestly.
These statements have not been evaluated by the Food and Drug Administration. J.P. Hemp Company products are not intended to diagnose, treat, cure, or prevent any disease.